Cargando…
CLINICAL EXPERIENCE WITH INTRAVENOUS IMMUNOGLOBULIN AND TNF-A INHIBITOR THERAPIES FOR RECURRENT PREGNANCY LOSS
Autores principales: | Sills, Eric Scott, Walsh, David J, Shkrobot, Lyuda V, Palermo, Gianpiero D, Walsh, Anthony PH |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Ulster Medical Society
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629025/ https://www.ncbi.nlm.nih.gov/pubmed/19252735 |
Ejemplares similares
-
Ovarian serous adenocarcinoma identified during IVF: diagnostic approach, surgical management, and reproductive outcome
por: Walsh, David J, et al.
Publicado: (2009) -
ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy
por: Harrity, Conor, et al.
Publicado: (2018) -
Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
por: Yang, Xiuhua, et al.
Publicado: (2020) -
Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
por: Yamamoto, Haruko, et al.
Publicado: (2022) -
Intrauterine pregnancy following low-dose gonadotropin ovulation induction and direct intraperitoneal insemination for severe cervical stenosis
por: Sills, E Scott, et al.
Publicado: (2002)